Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia/reperfusion‐induced injuryTiziano M. Scarabelli, Hisanori Suzuki, Sofia Mariotto et al.|FEBS Letters|2008Cited by 97
A Critical Review of the Use of Carvedilol in Ischemic Heart DiseaseCarol Chen‐Scarabelli, Tiziano M. Scarabelli, Rodeo Abrencillo et al.|American Journal of Cardiovascular Drugs|2012Cited by 36
A Critical Review of the Use of Carvedilol in Ischemic Heart DiseaseCarol Chen‐Scarabelli, Tiziano M. Scarabelli, Louis Saravolatz et al.|American Journal of Cardiovascular Drugs|2012Cited by 28